Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
HKEX:6618
JD Health International, Inc. (6618) Stock Price & Analysis
3 Followers
6618 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$22.35 - HK$59.60
Previous CloseHK$30.3
Volume13.99M
Average Volume (3M)6.46M
Market Cap
HK$96.64B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)39.7
Beta1.64
Next Earnings
Aug 20, 2024EPS Estimate
HK$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.76
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume6,458,142
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$37.00Price Target Upside22.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.59% Mutual Funds
4.14% Other Institutional Investors
93.26% Public Companies and
Individual Investors
6618 FAQ
What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$22.35 and its highest was HK$59.60 in the past 12 months.
What is JD Health International, Inc.’s market cap?
Currently, no data Available
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s upcoming earnings report date is Aug 20, 2024 which is in 91 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Mar 20, 2024. The company reported HK$0.198 earnings per share for the quarter, missing the consensus estimate of HK$0.216 by -HK$0.018.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is HK$0.37.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,189,465,000 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$0.198 in its last earnings report, missing expectations of HK$0.216. Following the earnings report the stock price went down -0.311%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
---
JD Health International, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.03%
12-Months-Change
Fundamentals
Return on Equity
4.57%
Trailing 12-Months
Asset Growth
2.88%
Trailing 12-Months
Company Description
JD Health International, Inc.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2021, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
---
6618 Stock 12 Month Forecast
Average Price Target
HK$37.00
▲(22.11% Upside)
Technical Analysis
China Modern Dairy Holdings Ltd.
―
Venus Medtech (Hangzhou), Inc. Class H
―
CStone Pharmaceuticals
―
Best Analysts Covering 6618
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
-21.68%
reiterated a buy rating 2 months ago
Copying Thomas Shen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -21.68% per trade.
---